Skip to main content
letter
. 2022 Feb 18;77(5):605–608. doi: 10.1111/anae.15677

Figure 1.

Figure 1

Logistic regression odds of 28‐day mortality for immunocompetent vs. immunocompromised patients, stratified by vaccine group: no virus immunity; first dose failure; and second dose failure. Odds adjusted for age; sex; ethnicity; socio‐economic status; and comorbidity